1 Market Overview 1.1 Acute Kidney Injury Treatment & Management Product Introduction 1.2 Global Acute Kidney Injury Treatment & Management Market Size Forecast 1.3 Acute Kidney Injury Treatment & Management Market Trends & Drivers 1.3.1 Acute Kidney Injury Treatment & Management Industry Trends 1.3.2 Acute Kidney Injury Treatment & Management Market Drivers & Opportunity 1.3.3 Acute Kidney Injury Treatment & Management Market Challenges 1.3.4 Acute Kidney Injury Treatment & Management Market Restraints 1.4 Assumptions and Limitations 1.5 Study Objectives 1.6 Years Considered 2 Competitive Analysis by Company 2.1 Global Acute Kidney Injury Treatment & Management Players Revenue Ranking (2023) 2.2 Global Acute Kidney Injury Treatment & Management Revenue by Company (2019-2024) 2.3 Key Companies Acute Kidney Injury Treatment & Management Manufacturing Base Distribution and Headquarters 2.4 Key Companies Acute Kidney Injury Treatment & Management Product Offered 2.5 Key Companies Time to Begin Mass Production of Acute Kidney Injury Treatment & Management 2.6 Acute Kidney Injury Treatment & Management Market Competitive Analysis 2.6.1 Acute Kidney Injury Treatment & Management Market Concentration Rate (2019-2024) 2.6.2 Global 5 and 10 Largest Companies by Acute Kidney Injury Treatment & Management Revenue in 2023 2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Acute Kidney Injury Treatment & Management as of 2023) 2.7 Mergers & Acquisitions, Expansion 3 Segmentation by Type 3.1 Introduction by Type 3.1.1 Prerenal Acute Kidney Injury 3.1.2 Intrinsic Renal Acute Kidney Injury 3.1.3 Postrenal Acute Kidney Injury 3.2 Global Acute Kidney Injury Treatment & Management Sales Value by Type 3.2.1 Global Acute Kidney Injury Treatment & Management Sales Value by Type (2019 VS 2023 VS 2030) 3.2.2 Global Acute Kidney Injury Treatment & Management Sales Value, by Type (2019-2030) 3.2.3 Global Acute Kidney Injury Treatment & Management Sales Value, by Type (%) (2019-2030) 4 Segmentation by Application 4.1 Introduction by Application 4.1.1 Hospitals 4.1.2 Ambulatory Surgical Centers 4.1.3 Others 4.2 Global Acute Kidney Injury Treatment & Management Sales Value by Application 4.2.1 Global Acute Kidney Injury Treatment & Management Sales Value by Application (2019 VS 2023 VS 2030) 4.2.2 Global Acute Kidney Injury Treatment & Management Sales Value, by Application (2019-2030) 4.2.3 Global Acute Kidney Injury Treatment & Management Sales Value, by Application (%) (2019-2030) 5 Segmentation by Region 5.1 Global Acute Kidney Injury Treatment & Management Sales Value by Region 5.1.1 Global Acute Kidney Injury Treatment & Management Sales Value by Region: 2019 VS 2023 VS 2030 5.1.2 Global Acute Kidney Injury Treatment & Management Sales Value by Region (2019-2024) 5.1.3 Global Acute Kidney Injury Treatment & Management Sales Value by Region (2025-2030) 5.1.4 Global Acute Kidney Injury Treatment & Management Sales Value by Region (%), (2019-2030) 5.2 North America 5.2.1 North America Acute Kidney Injury Treatment & Management Sales Value, 2019-2030 5.2.2 North America Acute Kidney Injury Treatment & Management Sales Value by Country (%), 2023 VS 2030 5.3 Europe 5.3.1 Europe Acute Kidney Injury Treatment & Management Sales Value, 2019-2030 5.3.2 Europe Acute Kidney Injury Treatment & Management Sales Value by Country (%), 2023 VS 2030 5.4 Asia Pacific 5.4.1 Asia Pacific Acute Kidney Injury Treatment & Management Sales Value, 2019-2030 5.4.2 Asia Pacific Acute Kidney Injury Treatment & Management Sales Value by Country (%), 2023 VS 2030 5.5 South America 5.5.1 South America Acute Kidney Injury Treatment & Management Sales Value, 2019-2030 5.5.2 South America Acute Kidney Injury Treatment & Management Sales Value by Country (%), 2023 VS 2030 5.6 Middle East & Africa 5.6.1 Middle East & Africa Acute Kidney Injury Treatment & Management Sales Value, 2019-2030 5.6.2 Middle East & Africa Acute Kidney Injury Treatment & Management Sales Value by Country (%), 2023 VS 2030 6 Segmentation by Key Countries/Regions 6.1 Key Countries/Regions Acute Kidney Injury Treatment & Management Sales Value Growth Trends, 2019 VS 2023 VS 2030 6.2 Key Countries/Regions Acute Kidney Injury Treatment & Management Sales Value 6.3 United States 6.3.1 United States Acute Kidney Injury Treatment & Management Sales Value, 2019-2030 6.3.2 United States Acute Kidney Injury Treatment & Management Sales Value by Type (%), 2023 VS 2030 6.3.3 United States Acute Kidney Injury Treatment & Management Sales Value by Application, 2023 VS 2030 6.4 Europe 6.4.1 Europe Acute Kidney Injury Treatment & Management Sales Value, 2019-2030 6.4.2 Europe Acute Kidney Injury Treatment & Management Sales Value by Type (%), 2023 VS 2030 6.4.3 Europe Acute Kidney Injury Treatment & Management Sales Value by Application, 2023 VS 2030 6.5 China 6.5.1 China Acute Kidney Injury Treatment & Management Sales Value, 2019-2030 6.5.2 China Acute Kidney Injury Treatment & Management Sales Value by Type (%), 2023 VS 2030 6.5.3 China Acute Kidney Injury Treatment & Management Sales Value by Application, 2023 VS 2030 6.6 Japan 6.6.1 Japan Acute Kidney Injury Treatment & Management Sales Value, 2019-2030 6.6.2 Japan Acute Kidney Injury Treatment & Management Sales Value by Type (%), 2023 VS 2030 6.6.3 Japan Acute Kidney Injury Treatment & Management Sales Value by Application, 2023 VS 2030 6.7 South Korea 6.7.1 South Korea Acute Kidney Injury Treatment & Management Sales Value, 2019-2030 6.7.2 South Korea Acute Kidney Injury Treatment & Management Sales Value by Type (%), 2023 VS 2030 6.7.3 South Korea Acute Kidney Injury Treatment & Management Sales Value by Application, 2023 VS 2030 6.8 Southeast Asia 6.8.1 Southeast Asia Acute Kidney Injury Treatment & Management Sales Value, 2019-2030 6.8.2 Southeast Asia Acute Kidney Injury Treatment & Management Sales Value by Type (%), 2023 VS 2030 6.8.3 Southeast Asia Acute Kidney Injury Treatment & Management Sales Value by Application, 2023 VS 2030 6.9 India 6.9.1 India Acute Kidney Injury Treatment & Management Sales Value, 2019-2030 6.9.2 India Acute Kidney Injury Treatment & Management Sales Value by Type (%), 2023 VS 2030 6.9.3 India Acute Kidney Injury Treatment & Management Sales Value by Application, 2023 VS 2030 7 Company Profiles 7.1 B. Braun Melsungen AG 7.1.1 B. Braun Melsungen AG Profile 7.1.2 B. Braun Melsungen AG Main Business 7.1.3 B. Braun Melsungen AG Acute Kidney Injury Treatment & Management Products, Services and Solutions 7.1.4 B. Braun Melsungen AG Acute Kidney Injury Treatment & Management Revenue (US$ Million) & (2019-2024) 7.1.5 B. Braun Melsungen AG Recent Developments 7.2 Baxter International, Inc. 7.2.1 Baxter International, Inc. Profile 7.2.2 Baxter International, Inc. Main Business 7.2.3 Baxter International, Inc. Acute Kidney Injury Treatment & Management Products, Services and Solutions 7.2.4 Baxter International, Inc. Acute Kidney Injury Treatment & Management Revenue (US$ Million) & (2019-2024) 7.2.5 Baxter International, Inc. Recent Developments 7.3 Asahi Kasei Medical Co., Ltd 7.3.1 Asahi Kasei Medical Co., Ltd Profile 7.3.2 Asahi Kasei Medical Co., Ltd Main Business 7.3.3 Asahi Kasei Medical Co., Ltd Acute Kidney Injury Treatment & Management Products, Services and Solutions 7.3.4 Asahi Kasei Medical Co., Ltd Acute Kidney Injury Treatment & Management Revenue (US$ Million) & (2019-2024) 7.3.5 Angion Biomedica Corp Recent Developments 7.4 Angion Biomedica Corp 7.4.1 Angion Biomedica Corp Profile 7.4.2 Angion Biomedica Corp Main Business 7.4.3 Angion Biomedica Corp Acute Kidney Injury Treatment & Management Products, Services and Solutions 7.4.4 Angion Biomedica Corp Acute Kidney Injury Treatment & Management Revenue (US$ Million) & (2019-2024) 7.4.5 Angion Biomedica Corp Recent Developments 7.5 AM-Pharma 7.5.1 AM-Pharma Profile 7.5.2 AM-Pharma Main Business 7.5.3 AM-Pharma Acute Kidney Injury Treatment & Management Products, Services and Solutions 7.5.4 AM-Pharma Acute Kidney Injury Treatment & Management Revenue (US$ Million) & (2019-2024) 7.5.5 AM-Pharma Recent Developments 7.6 Quark Pharmaceuticals, Inc 7.6.1 Quark Pharmaceuticals, Inc Profile 7.6.2 Quark Pharmaceuticals, Inc Main Business 7.6.3 Quark Pharmaceuticals, Inc Acute Kidney Injury Treatment & Management Products, Services and Solutions 7.6.4 Quark Pharmaceuticals, Inc Acute Kidney Injury Treatment & Management Revenue (US$ Million) & (2019-2024) 7.6.5 Quark Pharmaceuticals, Inc Recent Developments 7.7 Fresenius Medical Care AG & Co. KGaA 7.7.1 Fresenius Medical Care AG & Co. KGaA Profile 7.7.2 Fresenius Medical Care AG & Co. KGaA Main Business 7.7.3 Fresenius Medical Care AG & Co. KGaA Acute Kidney Injury Treatment & Management Products, Services and Solutions 7.7.4 Fresenius Medical Care AG & Co. KGaA Acute Kidney Injury Treatment & Management Revenue (US$ Million) & (2019-2024) 7.7.5 Fresenius Medical Care AG & Co. KGaA Recent Developments 8 Industry Chain Analysis 8.1 Acute Kidney Injury Treatment & Management Industrial Chain 8.2 Acute Kidney Injury Treatment & Management Upstream Analysis 8.2.1 Key Raw Materials 8.2.2 Raw Materials Key Suppliers 8.2.3 Manufacturing Cost Structure 8.3 Midstream Analysis 8.4 Downstream Analysis (Customers Analysis) 8.5 Sales Model and Sales Channels 8.5.1 Acute Kidney Injury Treatment & Management Sales Model 8.5.2 Sales Channel 8.5.3 Acute Kidney Injury Treatment & Management Distributors 9 Research Findings and Conclusion 10 Appendix 10.1 Research Methodology 10.1.1 Methodology/Research Approach 10.1.2 Data Source 10.2 Author Details 10.3 Disclaimer

List of Tables Table 1. Acute Kidney Injury Treatment & Management Market Trends Table 2. Acute Kidney Injury Treatment & Management Market Drivers & Opportunity Table 3. Acute Kidney Injury Treatment & Management Market Challenges Table 4. Acute Kidney Injury Treatment & Management Market Restraints Table 5. Global Acute Kidney Injury Treatment & Management Revenue by Company (2019-2024) & (US$ Million) Table 6. Global Acute Kidney Injury Treatment & Management Revenue Market Share by Company (2019-2024) Table 7. Key Companies Acute Kidney Injury Treatment & Management Manufacturing Base Distribution and Headquarters Table 8. Key Companies Acute Kidney Injury Treatment & Management Product Type Table 9. Key Companies Time to Begin Mass Production of Acute Kidney Injury Treatment & Management Table 10. Global Acute Kidney Injury Treatment & Management Companies Market Concentration Ratio (CR5 and HHI) Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Acute Kidney Injury Treatment & Management as of 2023) Table 12. Mergers & Acquisitions, Expansion Plans Table 13. Global Acute Kidney Injury Treatment & Management Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million) Table 14. Global Acute Kidney Injury Treatment & Management Sales Value by Type (2019-2024) & (US$ Million) Table 15. Global Acute Kidney Injury Treatment & Management Sales Value by Type (2025-2030) & (US$ Million) Table 16. Global Acute Kidney Injury Treatment & Management Sales Market Share in Value by Type (2019-2024) & (%) Table 17. Global Acute Kidney Injury Treatment & Management Sales Market Share in Value by Type (2025-2030) & (%) Table 18. Global Acute Kidney Injury Treatment & Management Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million) Table 19. Global Acute Kidney Injury Treatment & Management Sales Value by Application (2019-2024) & (US$ Million) Table 20. Global Acute Kidney Injury Treatment & Management Sales Value by Application (2025-2030) & (US$ Million) Table 21. Global Acute Kidney Injury Treatment & Management Sales Market Share in Value by Application (2019-2024) & (%) Table 22. Global Acute Kidney Injury Treatment & Management Sales Market Share in Value by Application (2025-2030) & (%) Table 23. Global Acute Kidney Injury Treatment & Management Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million) Table 24. Global Acute Kidney Injury Treatment & Management Sales Value by Region (2019-2024) & (US$ Million) Table 25. Global Acute Kidney Injury Treatment & Management Sales Value by Region (2025-2030) & (US$ Million) Table 26. Global Acute Kidney Injury Treatment & Management Sales Value by Region (2019-2024) & (%) Table 27. Global Acute Kidney Injury Treatment & Management Sales Value by Region (2025-2030) & (%) Table 28. Key Countries/Regions Acute Kidney Injury Treatment & Management Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030 Table 29. Key Countries/Regions Acute Kidney Injury Treatment & Management Sales Value, (2019-2024) & (US$ Million) Table 30. Key Countries/Regions Acute Kidney Injury Treatment & Management Sales Value, (2025-2030) & (US$ Million) Table 31. B. Braun Melsungen AG Basic Information List Table 32. B. Braun Melsungen AG Description and Business Overview Table 33. B. Braun Melsungen AG Acute Kidney Injury Treatment & Management Products, Services and Solutions Table 34. Revenue (US$ Million) in Acute Kidney Injury Treatment & Management Business of B. Braun Melsungen AG (2019-2024) Table 35. B. Braun Melsungen AG Recent Developments Table 36. Baxter International, Inc. Basic Information List Table 37. Baxter International, Inc. Description and Business Overview Table 38. Baxter International, Inc. Acute Kidney Injury Treatment & Management Products, Services and Solutions Table 39. Revenue (US$ Million) in Acute Kidney Injury Treatment & Management Business of Baxter International, Inc. (2019-2024) Table 40. Baxter International, Inc. Recent Developments Table 41. Asahi Kasei Medical Co., Ltd Basic Information List Table 42. Asahi Kasei Medical Co., Ltd Description and Business Overview Table 43. Asahi Kasei Medical Co., Ltd Acute Kidney Injury Treatment & Management Products, Services and Solutions Table 44. Revenue (US$ Million) in Acute Kidney Injury Treatment & Management Business of Asahi Kasei Medical Co., Ltd (2019-2024) Table 45. Asahi Kasei Medical Co., Ltd Recent Developments Table 46. Angion Biomedica Corp Basic Information List Table 47. Angion Biomedica Corp Description and Business Overview Table 48. Angion Biomedica Corp Acute Kidney Injury Treatment & Management Products, Services and Solutions Table 49. Revenue (US$ Million) in Acute Kidney Injury Treatment & Management Business of Angion Biomedica Corp (2019-2024) Table 50. Angion Biomedica Corp Recent Developments Table 51. AM-Pharma Basic Information List Table 52. AM-Pharma Description and Business Overview Table 53. AM-Pharma Acute Kidney Injury Treatment & Management Products, Services and Solutions Table 54. Revenue (US$ Million) in Acute Kidney Injury Treatment & Management Business of AM-Pharma (2019-2024) Table 55. AM-Pharma Recent Developments Table 56. Quark Pharmaceuticals, Inc Basic Information List Table 57. Quark Pharmaceuticals, Inc Description and Business Overview Table 58. Quark Pharmaceuticals, Inc Acute Kidney Injury Treatment & Management Products, Services and Solutions Table 59. Revenue (US$ Million) in Acute Kidney Injury Treatment & Management Business of Quark Pharmaceuticals, Inc (2019-2024) Table 60. Quark Pharmaceuticals, Inc Recent Developments Table 61. Fresenius Medical Care AG & Co. KGaA Basic Information List Table 62. Fresenius Medical Care AG & Co. KGaA Description and Business Overview Table 63. Fresenius Medical Care AG & Co. KGaA Acute Kidney Injury Treatment & Management Products, Services and Solutions Table 64. Revenue (US$ Million) in Acute Kidney Injury Treatment & Management Business of Fresenius Medical Care AG & Co. KGaA (2019-2024) Table 65. Fresenius Medical Care AG & Co. KGaA Recent Developments Table 66. Key Raw Materials Lists Table 67. Raw Materials Key Suppliers Lists Table 68. Acute Kidney Injury Treatment & Management Downstream Customers Table 69. Acute Kidney Injury Treatment & Management Distributors List Table 70. Research Programs/Design for This Report Table 71. Key Data Information from Secondary Sources Table 72. Key Data Information from Primary Sources Table 73. Business Unit and Senior & Team Lead Analysts List of Figures Figure 1. Acute Kidney Injury Treatment & Management Product Picture Figure 2. Global Acute Kidney Injury Treatment & Management Sales Value, 2019 VS 2023 VS 2030 (US$ Million) Figure 3. Global Acute Kidney Injury Treatment & Management Sales Value (2019-2030) & (US$ Million) Figure 4. Acute Kidney Injury Treatment & Management Report Years Considered Figure 5. Global Acute Kidney Injury Treatment & Management Players Revenue Ranking (2023) & (US$ Million) Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Acute Kidney Injury Treatment & Management Revenue in 2023 Figure 7. Acute Kidney Injury Treatment & Management Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023 Figure 8. Prerenal Acute Kidney Injury Picture Figure 9. Intrinsic Renal Acute Kidney Injury Picture Figure 10. Postrenal Acute Kidney Injury Picture Figure 11. Global Acute Kidney Injury Treatment & Management Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million) Figure 12. Global Acute Kidney Injury Treatment & Management Sales Value Market Share by Type, 2023 & 2030 Figure 13. Product Picture of Hospitals Figure 14. Product Picture of Ambulatory Surgical Centers Figure 15. Product Picture of Others Figure 16. Global Acute Kidney Injury Treatment & Management Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million) Figure 17. Global Acute Kidney Injury Treatment & Management Sales Value Market Share by Application, 2023 & 2030 Figure 18. North America Acute Kidney Injury Treatment & Management Sales Value (2019-2030) & (US$ Million) Figure 19. North America Acute Kidney Injury Treatment & Management Sales Value by Country (%), 2023 VS 2030 Figure 20. Europe Acute Kidney Injury Treatment & Management Sales Value (2019-2030) & (US$ Million) Figure 21. Europe Acute Kidney Injury Treatment & Management Sales Value by Country (%), 2023 VS 2030 Figure 22. Asia Pacific Acute Kidney Injury Treatment & Management Sales Value (2019-2030) & (US$ Million) Figure 23. Asia Pacific Acute Kidney Injury Treatment & Management Sales Value by Country (%), 2023 VS 2030 Figure 24. South America Acute Kidney Injury Treatment & Management Sales Value (2019-2030) & (US$ Million) Figure 25. South America Acute Kidney Injury Treatment & Management Sales Value by Country (%), 2023 VS 2030 Figure 26. Middle East & Africa Acute Kidney Injury Treatment & Management Sales Value (2019-2030) & (US$ Million) Figure 27. Middle East & Africa Acute Kidney Injury Treatment & Management Sales Value by Country (%), 2023 VS 2030 Figure 28. Key Countries/Regions Acute Kidney Injury Treatment & Management Sales Value (%), (2019-2030) Figure 29. United States Acute Kidney Injury Treatment & Management Sales Value, (2019-2030) & (US$ Million) Figure 30. United States Acute Kidney Injury Treatment & Management Sales Value by Type (%), 2023 VS 2030 Figure 31. United States Acute Kidney Injury Treatment & Management Sales Value by Application (%), 2023 VS 2030 Figure 32. Europe Acute Kidney Injury Treatment & Management Sales Value, (2019-2030) & (US$ Million) Figure 33. Europe Acute Kidney Injury Treatment & Management Sales Value by Type (%), 2023 VS 2030 Figure 34. Europe Acute Kidney Injury Treatment & Management Sales Value by Application (%), 2023 VS 2030 Figure 35. China Acute Kidney Injury Treatment & Management Sales Value, (2019-2030) & (US$ Million) Figure 36. China Acute Kidney Injury Treatment & Management Sales Value by Type (%), 2023 VS 2030 Figure 37. China Acute Kidney Injury Treatment & Management Sales Value by Application (%), 2023 VS 2030 Figure 38. Japan Acute Kidney Injury Treatment & Management Sales Value, (2019-2030) & (US$ Million) Figure 39. Japan Acute Kidney Injury Treatment & Management Sales Value by Type (%), 2023 VS 2030 Figure 40. Japan Acute Kidney Injury Treatment & Management Sales Value by Application (%), 2023 VS 2030 Figure 41. South Korea Acute Kidney Injury Treatment & Management Sales Value, (2019-2030) & (US$ Million) Figure 42. South Korea Acute Kidney Injury Treatment & Management Sales Value by Type (%), 2023 VS 2030 Figure 43. South Korea Acute Kidney Injury Treatment & Management Sales Value by Application (%), 2023 VS 2030 Figure 44. Southeast Asia Acute Kidney Injury Treatment & Management Sales Value, (2019-2030) & (US$ Million) Figure 45. Southeast Asia Acute Kidney Injury Treatment & Management Sales Value by Type (%), 2023 VS 2030 Figure 46. Southeast Asia Acute Kidney Injury Treatment & Management Sales Value by Application (%), 2023 VS 2030 Figure 47. India Acute Kidney Injury Treatment & Management Sales Value, (2019-2030) & (US$ Million) Figure 48. India Acute Kidney Injury Treatment & Management Sales Value by Type (%), 2023 VS 2030 Figure 49. India Acute Kidney Injury Treatment & Management Sales Value by Application (%), 2023 VS 2030 Figure 50. Acute Kidney Injury Treatment & Management Industrial Chain Figure 51. Acute Kidney Injury Treatment & Management Manufacturing Cost Structure Figure 52. Channels of Distribution (Direct Sales, and Distribution) Figure 53. Bottom-up and Top-down Approaches for This Report Figure 54. Data Triangulation